[Local treatment of 32 patients suffering from cutaneomucous herpes with rifamycin SV or rifampicin].
D005260:Female; D006561:Herpes Simplex / Q000150:complications / Q000188:drug therapy*; D006689:Hodgkin Disease / Q000150:complications; D006801:Humans; D007945:Leukemia, Lymphoid / Q000150:complications; D008297:Male; D012008:Recurrence; D012293:Rifampin / Q000008:administration & dosage* / Q000627:therapeutic use; D012294:Rifamycins / Q000008:administration & dosage* / Q000627:therapeutic use; D013997:Time Factors
D012294:Rifamycins; D012293:Rifampin
Traitement local de 32 malades atteints d'herpès cutanéo-muqueux par la rifamycine SV ou la rifampicine.